亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠成共創有限公司  

醫藥中間體 醫藥 保養

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:尹超
  • 電話:02788082182
  • 傳真:027-68886696
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 刺五加甙
刺五加甙
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2013-01-18 14:59
 
詳細信息
刺五加提取物 刺五加甙B+刺五加甙E 0.8% 1% 1.5% 2%
Acanthopanax senticosus (Rupr. et Maxim.)Harms 的干燥根及根莖.,有其植物固有的香氣。刺五加甙B、刺五加甙E1.0% 1.5%CAS NO】
刺五加甙B+E 0.8% 1.0%1.5%刺五加甙A(Eleutheroside A,即β-谷甾醇葡萄糖甙),刺五加甙B(即紫丁香甙Syringin),刺五加甙B1(即6,8—二甲氧基香豆素—7—葡萄糖甙),刺五加甙(即乙基半乳糖甙),刺五加甙D和E(為二種不同構型的紫丁香樹脂酚的葡萄糖甙)等。
此外,尚含多糖及1-芝麻脂素(1-Sesamin),其主要活性成分被認為是刺五加甙B和刺五加甙E。刺五加甙,其能刺激精神和身體活力。
眾多關于刺五加的科學出版物已證明了其抗疲勞作用,增強持久力和能力,增加機敏和學習能力。眾多用法都已在人體實驗中得到了證實。刺五加是病后康復,承受過多壓力或緊張,工作過量,慢性病導致身體虛弱的人群以及那些需要達到生理和心理性能高峰的人中非常受歡迎的自我藥療藥物。

©2025 武漢遠成共創有限公司 版權所有   技術支持:化工網   訪問量:8493  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |